Literature DB >> 20713651

Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet.

Nastaran Faghihnia1, Sotirios Tsimikas, Elizabeth R Miller, Joseph L Witztum, Ronald M Krauss.   

Abstract

Low-fat diets have been shown to increase plasma concentrations of lipoprotein(a) [Lp(a)], a preferential lipoprotein carrier of oxidized phospholipids (OxPLs) in plasma, as well as small dense LDL particles. We sought to determine whether increases in plasma Lp(a) induced by a low-fat high-carbohydrate (LFHC) diet are related to changes in OxPL and LDL subclasses. We studied 63 healthy subjects after 4 weeks of consuming, in random order, a high-fat low-carbohydrate (HFLC) diet and a LFHC diet. Plasma concentrations of Lp(a) (P < 0.01), OxPL/apolipoprotein (apo)B (P < 0.005), and OxPL-apo(a) (P < 0.05) were significantly higher on the LFHC diet compared with the HFLC diet whereas LDL peak particle size was significantly smaller (P < 0.0001). Diet-induced changes in Lp(a) were strongly correlated with changes in OxPL/apoB (P < 0.0001). The increases in plasma Lp(a) levels after the LFHC diet were also correlated with decreases in medium LDL particles (P < 0.01) and increases in very small LDL particles (P < 0.05). These results demonstrate that induction of increased levels of Lp(a) by an LFHC diet is associated with increases in OxPLs and with changes in LDL subclass distribution that may reflect altered metabolism of Lp(a) particles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713651      PMCID: PMC2952573          DOI: 10.1194/jlr.M005769

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  51 in total

1.  Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins.

Authors:  J W Gaubatz; R C Hoogeveen; A S Hoffman; K G Ghazzaly; H J Pownall; J Guevara; M L Koschinsky; J D Morrisett
Journal:  J Lipid Res       Date:  2001-12       Impact factor: 5.922

2.  Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a).

Authors:  Marja-Leena Silaste; Maire Rantala; Georg Alfthan; Antti Aro; Joseph L Witztum; Y Antero Kesäniemi; Sohvi Hörkkö
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-22       Impact factor: 8.311

3.  Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.

Authors:  David-Alexandre Trégouët; Inke R König; Jeanette Erdmann; Alexandru Munteanu; Peter S Braund; Alistair S Hall; Anika Grosshennig; Patrick Linsel-Nitschke; Claire Perret; Maylis DeSuremain; Thomas Meitinger; Ben J Wright; Michael Preuss; Anthony J Balmforth; Stephen G Ball; Christa Meisinger; Cécile Germain; Alun Evans; Dominique Arveiler; Gérald Luc; Jean-Bernard Ruidavets; Caroline Morrison; Pim van der Harst; Stefan Schreiber; Katharina Neureuther; Arne Schäfer; Peter Bugert; Nour E El Mokhtari; Jürgen Schrezenmeir; Klaus Stark; Diana Rubin; H-Erich Wichmann; Christian Hengstenberg; Willem Ouwehand; Andreas Ziegler; Laurence Tiret; John R Thompson; Francois Cambien; Heribert Schunkert; Nilesh J Samani
Journal:  Nat Genet       Date:  2009-02-08       Impact factor: 38.330

Review 4.  Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms.

Authors:  E J Parks; M K Hellerstein
Journal:  Am J Clin Nutr       Date:  2000-02       Impact factor: 7.045

5.  Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation.

Authors:  Peter Friedman; Sohvi Horkko; Daniel Steinberg; Joseph L Witztum; Edward A Dennis
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

6.  Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.

Authors:  J Danesh; R Collins; R Peto
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

Review 7.  Metabolic origins and clinical significance of LDL heterogeneity.

Authors:  Kaspar K Berneis; Ronald M Krauss
Journal:  J Lipid Res       Date:  2002-09       Impact factor: 5.922

8.  Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.

Authors:  Sotirios Tsimikas; Claes Bergmark; Reinaldo W Beyer; Raj Patel; Jennifer Pattison; Elizabeth Miller; Joseph Juliano; Joseph L Witztum
Journal:  J Am Coll Cardiol       Date:  2003-02-05       Impact factor: 24.094

9.  Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a).

Authors:  Celina Edelstein; Ditta Pfaffinger; Janet Hinman; Elizabeth Miller; Gregory Lipkind; Sotirios Tsimikas; Claes Bergmark; Godfrey S Getz; Joseph L Witztum; Angelo M Scanu
Journal:  J Biol Chem       Date:  2003-10-13       Impact factor: 5.157

10.  Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma.

Authors:  Masanori Aikawa; Seigo Sugiyama; Christopher C Hill; Sami J Voglic; Elena Rabkin; Yoshihiro Fukumoto; Frederick J Schoen; Joseph L Witztum; Peter Libby
Journal:  Circulation       Date:  2002-09-10       Impact factor: 29.690

View more
  19 in total

1.  Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial.

Authors:  Young Sup Byun; Jun-Hee Lee; Benoit J Arsenault; Xiaohong Yang; Weihang Bao; David DeMicco; Rachel Laskey; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

Review 2.  Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.

Authors:  Adam Taleb; Joseph L Witztum; Sotirios Tsimikas
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 3.  The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.

Authors:  John D Brunzell; Alberto Zambon; Samir S Deeb
Journal:  Biochim Biophys Acta       Date:  2011-09-25

Review 4.  The role of advanced lipid testing in the prediction of cardiovascular disease.

Authors:  Alvin Chandra; Anand Rohatgi
Journal:  Curr Atheroscler Rep       Date:  2014-03       Impact factor: 5.113

5.  A short-term religious "fast" from animal products has a minimal impact on cardiometabolic health biomarkers irrespective of concurrent shifts in distinct plant-based food groups.

Authors:  Hilary J Bethancourt; Mario Kratz; Kathleen O'Connor
Journal:  Am J Clin Nutr       Date:  2019-09-01       Impact factor: 7.045

6.  Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.

Authors:  Gregor Leibundgut; Kiyohito Arai; Alexina Orsoni; Huiyong Yin; Corey Scipione; Elizabeth R Miller; Marlys L Koschinsky; M John Chapman; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2012-04-17       Impact factor: 24.094

7.  Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.

Authors:  Raul D Santos; Frederick J Raal; Alberico L Catapano; Joseph L Witztum; Elisabeth Steinhagen-Thiessen; Sotirios Tsimikas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-01-22       Impact factor: 8.311

Review 8.  Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.

Authors:  Calvin Yeang; Michael J Wilkinson; Sotirios Tsimikas
Journal:  Curr Opin Cardiol       Date:  2016-07       Impact factor: 2.161

Review 9.  Lipoprotein (a): impact by ethnicity and environmental and medical conditions.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Lars Berglund
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

10.  Consumption of a defined, plant-based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks.

Authors:  Rami S Najjar; Carolyn E Moore; Baxter D Montgomery
Journal:  Clin Cardiol       Date:  2018-08-17       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.